Skip to main content
. 2023 Apr 25;15(5):1046. doi: 10.3390/v15051046

Table 1.

Baseline characteristics of patients.

Variables n = 38
Sex male, n (%) 23 (60.5)
Age, median (IQR) 53 (46–59)
Risk factor, n (%):

  •   - MSM *

 18 (47.4)

  •   - Heterosexual

 13 (34.2)

  •   - PWID *

 6 (15.8)

  •   - Other/Unknown

 1 (2.6)
CDC, C, n (%) 14 (36.8)
HCV, n (%) 4 (10.5)
HBV, n (%) 4 (10.5)
Zenith HIV-RNA Log10/cp/mL, median (IQR) 5.33 (4.70–5.70)
Nadir CD4+ cell/mm3, median (IQR) 102 (24–231)
Years of HIV infection, median (IQR) 14.3 (5.8–21.8)
Years of ARV *, median (IQR) 12.2 (5.5–18.8)
Years of virological suppression, median (IQR) 8.4 (3.9–16.1)
LDL cholesterol at baseline, median (IQR) 122 (IQR 106.3–138.8)
HDL cholesterol at baseline, median (IQR) 52.31 (IQR 43.04–63.09)
Triglycerides at baseline, median (IQR) 119.09 (IQR 81.77–155.93)
Individuals on hypolipemic therapy, n (%) 2 (5.3)
Reasons of switching to DOR, n (%):

  •   - Simplification

 25 (65.8)

  •   - Dyslipidemia

 1 (2.6)

  •   - Toxicity

 10 (26.3)

  •   - Other/Unknown

 2 (5.3)

* MSM, Men who have sex with men; PWID, people who inject drugs; ARV, antiretroviral therapy.